Lv2
168 积分 2025-05-30 加入
CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
3天前
已完结
Dual-target CAR-T cell therapy: A new strategy to improve the therapeutic effect of hematological malignancies
5天前
已完结
OX40–heparan sulfate binding facilitates CAR T cell penetration into solid tumors in mice
6天前
已完结
A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity
6天前
已完结
Optimal pairing of binder and costimulatory domains improves dual CAR T cell efficacy
7天前
已完结
Coated Oncolytic Viruses Based “Double Strike” Strategy Triggering CD19 CAR-T Therapy in Gastrointestinal Tumors
4个月前
已关闭
Engineered TCR-T cells secreting IFNα/anti-PD-L1 potentiate endogenous immunity to synergistically bolster the efficacy against solid tumors
4个月前
已完结
An overview on display systems (phage, bacterial, and yeast display) for production of anticancer antibodies; advantages and disadvantages
4个月前
已完结
Ginsenoside, a potential natural product against liver diseases: a comprehensive review from molecular mechanisms to application
6个月前
已完结
Extracellular Vesicles‐Derived Hybrid Nanoplatforms for Amplified CD47 Blockade‐Based Cancer Immunotherapy
10个月前
已完结
皖公网安备34019202002308
